Vaxart, Inc. Gains 40.02%
Tue 14 Jul 20 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) rocketted at $16.97, a gain of 40%. On Mon 13 Jul 20, VXRT:NASDAQ touched a New 2-Week High of $12.12. The stock appeared on our News Catalysts scanner on Sat 11 Jul 20 at 09:16 AM in the 'BIOTECH' category. From Mon 29 Jun 20, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Fri 26 Jun 20 at $14.3 with a volume of 230M+.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Perceptron, Inc. (PRCP:NASDAQ), 107.01%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 90.97%
- INmune Bio, Inc. (INMB:NASDAQ), 77.97%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 57.21%
- IMV Inc. (IMV:NASDAQ), 54.33%
- Dare Bioscience, Inc. (DARE:NASDAQ), 50.5%
- Vaxart, Inc. (VXRT:NASDAQ), 40.02%
- Caladrius Biosciences, Inc. (CLBS:NASDAQ), 38.89%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 33.33%
- VIVUS, Inc. (VVUS:NASDAQ), 32.45%